Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories

被引：13

作者：

Freydiere, AM

Perry, JD

Faure, O

Willinger, B

Tortorano, AM

Nicholson, A

Peman, J

Verweij, PE

机构：

[1] Hop Debrousse, Hosp Civils Lyon, Bacteriol Lab, F-69322 Lyon 05, France

[2] Ctr Hosp Univ, Grenoble, France

[3] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

[4] Med Univ Vienna, Div Clin Microbiol, Inst Med Microbiol & Hyg, Vienna, Austria

[5] Univ Milan, Milan, Italy

[6] Univ Valencia, Hosp La Fe, Valencia, Spain

[7] Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2004年 / 42卷 / 10期

关键词：

D O I：

10.1128/JCM.42.10.4870-4872.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

引用

页码：4870 / 4872

页数：3

共 21 条

[1] Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates
Baumgartner, C
Freydiere, AM
Gille, Y
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) : 454 - 456
[2] Global distribution and outcomes for Candida species causing invasive candidiasis:: Results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis
Colombo, AL
Perfect, J
DiNubile, M
Bartizal, K
Motyl, M
Hicks, P
Lupinacci, R
Sable, C
Kartsonis, N
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (08) : 470 - 474
[3] Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata
Fenn, JP
Billetdeaux, E
Segal, H
Skodack-Jones, L
Padilla, PE
Bale, M
Carroll, K
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) : 3387 - 3389
[4] Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans
Fidel, PL
Vazquez, JA
Sobel, JD
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) : 80 - +
[5] Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT
Freydiere, AM
Robert, R
Ploton, C
Marot-Leblond, A
Monerau, F
Vandenesch, F
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3861 - 3863
[6] Identification of Candida glabrata by a 30-second trehalase test
Freydière, AM
Parant, F
Noel-Baron, F
Crepy, M
Treny, A
Raberin, H
Davidson, A
Odds, FC
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3602 - 3605
[7] Yeast identification in the clinical microbiology accepted 15 August 2000 laboratory: phenotypical methods
Freydiere, AM
Guinet, R
Boiron, P
[J]. MEDICAL MYCOLOGY, 2001, 39 (01) : 9 - 33
[8] Freydiere AM, 1996, J CLIN MICROBIOL, V34, P2048, DOI 10.1128/JCM.34.8.2048-2048.1996
[9] Evaluation of candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species
Fricker-Hidalgo, H
Orenga, S
Lebeau, B
Pelloux, H
Brenier-Pinchart, MP
Ambroise-Thomas, P
Grillot, R
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) : 1647 - 1649
[10] Screening protocol for Torulopsis (Candida) glabrata
Land, G
Burke, J
Shelby, C
Rhodes, J
Collett, J
Bennett, I
Johnson, J
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) : 2300 - 2303

← 1 2 3 →